A carregar...
Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab
We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.
Na minha lista:
| Publicado no: | Clin Transl Allergy |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149008/ https://ncbi.nlm.nih.gov/pubmed/30258566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-018-0222-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|